Home > Financial Ratios > GENPHARMASEC

GENPHARMASEC
Price to Cash Earnings (PCE)

    Back to All Ratios
GENPHARMASEC is part of below Screeners ↓
Top Undervalued Small Cap Stocks
Best Quarterly Growth Small Cap Stocks
COMMUNITY POLL
for GENPHARMASEC
Please provide your vote to see the results

GENPHARMASEC Last 5 Year Price to Cash Earnings (PCE) History

[Consolidated]

Mar2024Mar2023
   PCE(x) -970.7575.24

What is the latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC ?

The latest Price to Cash Earnings (PCE) ratio of GENPHARMASEC is -970.75 based on Mar2024 Consolidated results.
Year Price to Cash Earnings (PCE)
Mar2024-970.75
Mar202375.24

How is Price to Cash Earnings (PCE) of GENPHARMASEC Trending?

Years Price to Cash Earnings (PCE) % Change
Mar2024 -970.75
Negative
Mar2023 75.24 -

Other Financial Ratios of GENPHARMASEC


Compare Price to Cash Earnings (PCE) ratio of peers of GENPHARMASEC

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GENPHARMASEC ₹110.7 Cr 1% -1.5% -12.5% Stock Analytics
SUDARSHAN CHEMICAL INDUSTRIES ₹11,266.0 Cr -0.8% 13.8% 47.8% Stock Analytics
KIRI INDUSTRIES ₹3,174.0 Cr -0.4% -9% 46.9% Stock Analytics
VIDHI SPECIALTY FOOD INGREDIENTS ₹1,847.5 Cr -4.1% -7.9% -16.3% Stock Analytics
SHREE PUSHKAR CHEMICALS & FERTILISERS ₹1,092.5 Cr -0.4% -10.3% 42.3% Stock Analytics
BODAL CHEMICALS ₹862.7 Cr 3.3% -10.9% -13% Stock Analytics


GENPHARMASEC Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GENPHARMASEC

1%

-1.5%

-12.5%

SENSEX

2%

0.1%

1.8%


You may also like the below Video Courses